We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Dr. Martens Plc | LSE:DOCS | London | Ordinary Share | GB00BL6NGV24 | ORD GBP0.01 |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| 1.35 | 1.85% | 74.45 | 576,787 | 15:02:41 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| 74.15 | 74.50 | 74.90 | 73.10 | 73.10 | |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Footwear-wholesale | 787.6M | 4.5M | 0.0047 | 404.26 | 705.58M |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| 15:02:00 | AT | 365 | 74.45 | GBX |
| Date | Time | Source | Headline |
|---|---|---|---|
| 17/6/2025 | 10:00 | UK RNS | Dr. Martens PLC Director/PDMR Shareholding |
| 17/6/2025 | 09:00 | UK RNS | Dr. Martens PLC Annual Financial Report |
| 12/6/2025 | 16:13 | UK RNS | Dr. Martens PLC Director/PDMR Shareholding |
| 05/6/2025 | 09:54 | ALNC |  Dr Martens profit slumps but shares jump on growth outlook |
| 05/6/2025 | 07:00 | UK RNS | Dr. Martens PLC Final Results |
| 02/6/2025 | 14:05 | UK RNS | Dr. Martens PLC Block listing Interim Review |
| 30/5/2025 | 10:52 | UK RNS | Dr. Martens PLC Total Voting Rights |
| 29/5/2025 | 12:56 | ALNC | IN BRIEF: Dr Martens hires new chief brand officer from adidas |
| 27/5/2025 | 08:45 | UK RNS | Dr. Martens PLC Director Declaration |
| 14/5/2025 | 14:20 | UK RNS | Dr. Martens PLC Director/PDMR Shareholding |
Dr. Martens (DOCS) Share Charts1 Year Dr. Martens Chart |
|
1 Month Dr. Martens Chart |
Intraday Dr. Martens Chart |
| Date | Time | Title | Posts |
|---|---|---|---|
| 10/6/2025 | 14:06 | Dr. Martens | 914 |
| 22/4/2024 | 07:15 | Dr Martens - just mucking about (please ignore) | 11 |
| Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
|---|---|---|---|---|
| 14:02:00 | 74.45 | 365 | 271.74 | AT |
| 14:02:00 | 74.45 | 461 | 343.21 | AT |
| 14:02:00 | 74.45 | 105 | 78.17 | AT |
| 13:58:08 | 74.15 | 2 | 1.48 | O |
| 13:50:36 | 74.45 | 33 | 24.57 | O |
| Top Posts |
|---|
Posted at 20/6/2025 09:20 by Dr. Martens Daily Update Dr. Martens Plc is listed in the Footwear-wholesale sector of the London Stock Exchange with ticker DOCS. The last closing price for Dr. Martens was 73.10p.Dr. Martens currently has 965,229,918 shares in issue. The market capitalisation of Dr. Martens is £1,833,936,844. Dr. Martens has a price to earnings ratio (PE ratio) of 404.26. This morning DOCS shares opened at 73.10p |
Posted at 10/6/2025 07:08 by bigbigdave RBC RAISES DR. MARTENS PRICE TARGET TO 90 (60) PENCE - 'SECTOR PERFORM' |
Posted at 05/6/2025 09:24 by the white house Above guidance, inventory down & debt well down. Price drop from 400 to 50 in 4 years gives some idea of upside potential, given patience & continued easy reversal of some previous tremendously poor logistic decisions Congratulations |
Posted at 03/4/2025 13:02 by velocytongo Most Docs are made in Vietnam which was the hardest hit by the Trump tariffs. |
Posted at 27/2/2025 07:07 by bigbigdave BERENBERG STARTS DR, MARTENS WITH 'BUY' - PRICE TARGET 102 PENCE |
Posted at 27/1/2025 10:15 by mr5k listened to the call and it seems that Xmas discounting was rife in Germany and UK. It's good they resisted (they discount non core items) to maintain brand integrity but sales were a bit softer.encouraging signs but still too early to call orders for aut/wint 2025. Wholesale inventory levels are low in the us (which has been the case for a year) and represents an opportunity. Asia (Japan and China) was strong. and they are set to hit the inventory reduction target. i like ije and the way he talks about the brand and appears to be on top on the business. i bought early and doubled down when the market got frightened about the placing. as someone has said, turnarounds take time (a lot longer than one anticipates). going forward, this is a global brand (which they are taking care not to trash) with a global runway and with scope to grow.it's easy to see 20p in earnings with a 20 p/e in the next five years and growth. That's a share of 400p. dyor |
Posted at 27/1/2025 08:27 by the white house Agreed, serious signs of stabilisation & turnaround with positive news already from USA, Japan & Wholesale markets. Given other high st commentary, trading conditions & share price the worst may be behind |
Posted at 20/9/2024 15:22 by tomboyb DOCs net debt going in the wrong direction -And cash depreciating - Overall results this year will therefore be very second-half weighted, particularly from a profit perspective. Share price may well be very telling here - |
Posted at 16/7/2024 14:52 by mr5k Burberry's issues are very different from Docs. High-end consumer brands have pushed prices beyond inflation for so long that many buyers have said enough. Also, BRBY was trying to elevate the brand to Dior and Versace levels and that has not worked.I own a BRBY trench coat that cost me £120 25 years ago (as did many colleagues where I worked). That same coat now costs £1,500. Docs pricing is not out of whack with the price of other branded boots (Blundstones (a little more), Birkenstocks (more expensive) Russell and Bromley (even more expensive) and the price points are accessible. In terms of Asian exposure, Japan and S Korea are performing well (atm) and they closed their operations in China. BRBY is particularly exposed to the latter in terms of direct sales and London, where the duty-free sales benefit was dumped by the Tories (another Brexit benefit). Docs problems are in the US where the brand is less well established and the market is not as deep as management anticpated. |
Posted at 17/4/2024 11:50 by itisonlymoney darrin, thanks for the detail on the new ceo. Btw, does that look like the profile for a good fashion brand ceo? Big salary maybe. I have doubts. a senior director for apple retail - he's had lots of people around him to generate any success there. snr directors like to take all the credit if things go well, but out on their own, they often fail, so he's an unknown quantity at this point. does anyone here know how he did at wolf olins?huckers, I've asked the same question. my instinct atm is that this fifth profit warning and the change of leadership (a necessary move) with an untested ceo who has apparently been on the board (as a non-exec rather than ops management) throughout this car crash, creates massive uncertainty on top of the forecast for much lower profits. there's nothing but shifting sand under the strategy and the forecasts, plus the global environment does not look good - major european war which it looks like russia will now win, and the prospect of a middle eastern war. Docs has a high valuation based on its brand appeal but the retail market is not validating that appeal by buying the boots in huge numbers, so i think the share price has to reflect actual profit without a brand premium. that's my thinking and that leads me to guess that the share price is going steadily down for sometime now. i haven't got the confidence in that prediction to actually short the shares though, because there's no telling when a bid for the company could come. right now i'm watching. if the share price gets to 30p, i will almost certainly be a buyer. |
Posted at 28/11/2022 14:32 by essentialinvestor As the DOCS share price is given to large % moves in either direction, there are likelyto be ample trading opportunities for those astute/lucky enough to catch some of those. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
